Calidi Biotherapeutics, Inc.
CLDI
$0.19
$0.015.19%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -41.61% | 446.92% | 531.46% | 823.97% | 392.10% |
| Total Receivables | -- | -- | -72.38% | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 9.04% | 256.48% | -6.22% | 8.56% | -49.67% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -6.02% | 24.07% | 66.50% | 15.57% | 10.67% |
| Total Current Assets | -38.83% | 396.53% | 272.25% | 493.44% | 137.67% |
|
|
|||||
| Total Current Assets | -38.83% | 396.53% | 272.25% | 493.44% | 137.67% |
| Net Property, Plant & Equipment | -35.24% | -32.19% | -28.76% | -30.87% | -28.82% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -9.21% | -35.48% | -82.38% | -71.54% | -59.25% |
| Total Assets | -37.55% | 110.74% | 45.41% | 103.43% | 41.55% |
|
|
|||||
| Total Accounts Payable | -70.44% | -67.88% | -73.02% | -69.09% | -27.91% |
| Total Accrued Expenses | -39.31% | -39.32% | -53.25% | -68.25% | -45.21% |
| Short-term Debt | -- | -- | -- | -- | -10.40% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -61.83% | -51.57% | -41.14% | -46.96% | 184.94% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -58.56% | -55.15% | -58.99% | -63.71% | -7.19% |
|
|
|||||
| Total Current Liabilities | -58.56% | -55.15% | -58.99% | -63.71% | -7.19% |
| Long-Term Debt | 0.00% | -74.72% | -68.83% | -82.22% | -70.87% |
| Short-term Debt | -- | -- | -- | -- | -10.40% |
| Capital Leases | -77.49% | -64.03% | -53.84% | -44.06% | -38.83% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -10.16% | 14.20% | -81.77% | -87.52% | -95.28% |
| Total Liabilities | -58.26% | -58.49% | -59.99% | -64.67% | -33.09% |
|
|
|||||
| Common Stock & APIC | 17.94% | 34.53% | 33.08% | 44.96% | 34.90% |
| Retained Earnings | -16.35% | -16.96% | -17.64% | -18.64% | -22.24% |
| Treasury Stock & Other | 53.57% | 82.43% | 51.85% | -336.36% | 40.43% |
| Total Common Equity | 145.05% | 167.28% | 115.01% | 147.63% | 118.63% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 145.05% | 167.28% | 115.01% | 147.63% | 118.63% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -42.27% | -- | -- | -- |
| Total Equity | 91.01% | 173.46% | 117.67% | 150.09% | 123.90% |
|
|
|||||